Summary

This report is an essential source for data, analysis and strategic insight into the medical equipment business of Novo Nordisk A/S. The report provides key information relating to Novo Nordisk A/S  medical equipment revenue, market share by sector and country, financial and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and products, and provides an analysis of its key medical equipment revenue lines. It inspects the company's strategic strengths and weaknesses.

Scope

-Revenues for the medical equipment markets and sub-sectors by country and region.
-Provides the share of market and sub sectors by country and region.
-Detailed breakdown revenues contributed by the medical equipment business operations.
-Provides summary of the medical equipment pipeline products that the company is developing.
-Critical analysis of the company's strengths, weaknesses opportunities and threats.
-Provides summary analysis of key revenue lines and strategy.
-Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
-Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

-A single source to fulfill all of your business and competitor intelligence needs
-Research your competitor's business structure, strategy and prospects.
-Counter your competitor's strengths and target their weaknesses.
-Identify your competitor's key revenue streams by market and geography.
-Identify and assess potential corporate and investment opportunities.
-Support sales activities by understanding your customers businesses better.
-Identify potential competitor products before they reach market.
-Qualify prospective partners and suppliers.

Table of Contents

1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
3 Definitions of Markets/Categories Covered 9
3.1 Diabetes Care Devices 9
3.1.1 Insulin Delivery 9
4 Company Snapshot 10
4.1 Key Information 10
4.2 Company Overview 10
4.3 Financial Performance 10
4.4 SWOT Snapshot 10
4.5 Business Overview 11
4.6 Major Products and Services 12
4.6.1 Overview 12
5 History 13
6 SWOT Analysis 15
6.1 Overview 15
6.2 Novo Nordisk A/S Strengths 15
6.2.1 Diabetes Care Division 15
6.2.2 Strong Presence Across Geographies 16
6.2.3 Expanding Operating Margin 16
6.2.4 Efficient Use of Resources 16
6.3 Novo Nordisk A/S Weaknesses 16
6.3.1 Discontinued Development of AERx and Norditropin 16
6.4 Novo Nordisk A/S Opportunities 16
6.4.1 Product Pipeline 16
6.4.2 Growing Incidence of Diabetes 17
6.4.3 Collaboration with Cellartis and Lund University 17
6.4.4 Emerging Markets 17
6.4.5 Levemir's Continued Expansion into Newer Markets 17
6.4.6 Changing Demographics 17
6.5 Novo Nordisk A/S Threats 18
6.5.1 Intense Competition 18
6.5.2 Liability Claims 18
6.5.3 Changing Political Climate in the US 18
6.5.4 Tightening of the FDA's Regulatory Oversight 18
6.5.5 Growing Parallel Trade 18
7 Competitors 19
8 Novo Nordisk A/S Medical Equipment Market Share Analysis 20
8.1 Novo Nordisk A/S, Diabetes Care Devices, Global, Market Share (2008) 20
8.2 Novo Nordisk A/S, APAC, Market Share (2008) 21
8.3 Novo Nordisk A/S, Europe, Market Share (2008) 22
8.4 Novo Nordisk A/S, MEA, Market Share (2008) 23
8.5 Novo Nordisk A/S, North America, Market Share (2008) 24
8.6 Novo Nordisk A/S, SCA, Market Share (2008) 25
9 Key Employees 26
10 Key Employee Biographies 27
11 Company Statement 29
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Recent Developments 34
13.1 Strategy And Business Planning 34
13.1.1 Jun 02, 2009: Novo Nordisk To Initiate Comparative Study For Levemir 34
13.2 Financial Announcements 34
13.2.1 Apr 30, 2009: Novo Posts Profit Of DKK2.6 Billion For Q1 2009 34
13.2.2 Jan 29, 2009: Novo Reports 2008 Results 35
13.2.3 Oct 30, 2008: Novo Reports First Nine Months 2008 Results 37
13.2.4 Aug 28, 2008: Novo spends $0.35 Million On Lobbying In 2Q 2008 38
13.2.5 Aug 07, 2008: Novo Reports 1H 2008 Results 38
13.3 Research And Development 40
13.3.1 Jun 02, 2009: Novo Nordisk To Initiate Comparative Study For Levemir 40
13.4 Corporate Communications 41
13.4.1 Feb 17, 2009: Novo Nordisk Appoints VP, National Diabetes Sales, Managed Care And Government Accounts 41
13.5 Legal and Regulatory 41
13.5.1 May 11, 2009: Novo Nordisk Reaches Settlements With SEC And DOJ 41
13.6 Product News 41
13.6.1 May 29, 2009: Study Reveals Novo Nordisk's Next Generation FlexPen Has A Significantly Lower Injection Force Than SoloStar And KwikPen 41
13.6.2 Sep 08, 2008: Novo Nordisk Launches A Next Generation Of FlexPen 42
13.7 Other Significant Developments 42
13.7.1 Jun 07, 2009: Novo Nordisk's Liraglutide To Reduce Blood Sugar, Weight 42
14 Appendix 44
14.1 Research Methodology 45
14.2 Secondary Research 46
14.3 Primary Research 46
14.4 Models 47
14.5 Forecasts 47
14.6 Expert Panels 47
14.7  Consulting 48
14.8 Contact Us 48
14.9 Disclaimer 48

1.1 List of Tables
Table 1:Novo Nordisk A/S, Key Facts, 2009 10
Table 2:Novo Nordisk A/S, SWOT Analysis, 2008 15
Table 3:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, Global, Revenue ($ mn) and Market Share (%), 2008 20
Table 4:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, APAC, Revenue ($ mn) and Market Share (%), 2008 21
Table 5:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, Europe, Revenue ($ mn) and Market Share (%), 2008 22
Table 6:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, MEA, Revenue ($ mn) and Market Share (%), 2008 23
Table 7:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, North America, Revenue ($ mn) and Market Share (%), 2008 24
Table 8:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, SCA, Revenue ($ mn) and Market Share (%), 2008 25
Table 9:Novo Nordisk A/S, Key Employees 26
Table 10:Novo Nordisk A/S, Other Locations 32
Table 11:Novo Nordisk A/S, Subsidiaries 32

1.2 List of Figures
Figure 1:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, Global, Market Share (%), 2008 20
Figure 2:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, APAC, Market Share (%), 2008 21
Figure 3:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, Europe, Market Share (%), 2008 22
Figure 4:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, MEA, Market Share (%), 2008 23
Figure 5:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, North America, Market Share (%), 2008 24
Figure 6:Novo Nordisk A/S, Diabetes Care Devices, Insulin Delivery, SCA, Market Share (%), 2008 25
Figure 7:  Methodology 45